Clinical Trial Update: A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) [Phase 1]

View source ↗

Summary

This Phase 1 multiple-dose study evaluated oral oseltamivir in participants with end-stage renal disease on hemodialysis or CAPD to assess safety and pharmacoki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Tamiflu (oseltamivir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: End Stage Renal Disease | Phase 1 | Status: COMPLETED | Results posted: 2016-02-15